Shao L, Frigon N L, Sehy D W, Yu A L, Lofgren J, Schwall R, Yu J
Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037.
Exp Hematol. 1992 Nov;20(10):1235-42.
In studies of the regulation of hematopoiesis, increasing attention has focused on the role of bone marrow stromal cells as rich sources of various cytokines. Present studies indicate that marrow stromal cells and monocytes produce activin A, implicating this new cytokine in the paracrine control of hematopoiesis. Activin A, which was initially recognized as a beta A beta A dimeric gonadal protein, was found to potentiate the proliferation and differentiation of erythroid progenitors; both purified erythroid colony-forming units (CFU-E) and K562 cells possess high affinity receptors specific for activin A. Present studies using Western and Northern blots demonstrate the presence of beta A subunits of activin A in the conditioned medium of monocytes and stromal cells and its RNA transcripts in these cells. The presence of functional and homodimeric beta A beta A activin molecule was confirmed through bioassay with or without a blocking antiserum against activin A or an activin binding protein, follistatin; its presence is further supported by a specific enzyme-linked immunosorbent assay (ELISA) in which a monoclonal antibody reacted only with the beta A beta A dimeric form of this molecule. In other experiments, the production of activin A was found to be regulated by various cytokines and regulators. The production of activin A in monocytes was stimulated more than ninefold by treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF). Activin A expression was also stimulated, albeit less potently, by bacterial lipopolysaccharide (LPS) and gamma-interferon. On the other hand, the expression of activin A in marrow stromal cells was upregulated by incubation with tumor necrosis factor-alpha (TNF-alpha), LPS, and interleukin 1 alpha (IL-1 alpha). Therefore, we propose that the local production of activin A in the microenvironment within bone marrow may fine tune the regulation of steady-state hematopoiesis. In addition, this factor may normally be produced at minimal levels, but under certain situations may be further induced to provide important biological functions.
在造血调控的研究中,骨髓基质细胞作为多种细胞因子的丰富来源,其作用受到越来越多的关注。目前的研究表明,骨髓基质细胞和单核细胞可产生激活素A,这表明这种新的细胞因子参与造血的旁分泌调控。激活素A最初被认为是一种βAβA二聚体性腺蛋白,现已发现它能增强红系祖细胞的增殖和分化;纯化的红系集落形成单位(CFU-E)和K562细胞都拥有对激活素A特异的高亲和力受体。目前使用蛋白质免疫印迹法(Western blot)和核酸分子杂交技术(Northern blot)的研究表明,单核细胞和基质细胞的条件培养基中存在激活素A的βA亚基,且这些细胞中有其RNA转录本。通过使用或不使用抗激活素A的封闭抗血清或激活素结合蛋白卵泡抑素(follistatin)的生物测定,证实了功能性同二聚体βAβA激活素分子的存在;一种单克隆抗体仅与该分子的βAβA二聚体形式反应的特异性酶联免疫吸附测定(ELISA)进一步支持了其存在。在其他实验中,发现激活素A的产生受多种细胞因子和调节剂的调控。用粒细胞-巨噬细胞集落刺激因子(GM-CSF)处理可使单核细胞中激活素A的产生增加9倍以上。细菌脂多糖(LPS)和γ-干扰素也能刺激激活素A的表达,尽管作用较弱。另一方面,用肿瘤坏死因子-α(TNF-α)、LPS和白细胞介素1α(IL-1α)孵育可上调骨髓基质细胞中激活素A的表达。因此,我们认为骨髓微环境中激活素A的局部产生可能对稳态造血的调控起到微调作用。此外,该因子通常可能以最低水平产生,但在某些情况下可能会被进一步诱导以发挥重要的生物学功能。